• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    12 Consumer Staples Stocks Moving In Monday's After-Market Session

    12/18/23 4:31:45 PM ET
    $AGRI
    $BTTR
    $CHSN
    $DTCK
    Metal Fabrications
    Industrials
    Beverages (Production/Distribution)
    Consumer Staples
    Get the next $AGRI alert in real time by email

    Gainers

    • Better Choice Co (AMEX:BTTR) shares moved upwards by 13.4% to $0.4 during Monday's after-market session. The company's market cap stands at $12.8 million.
    • Chanson International (NASDAQ:CHSN) shares increased by 11.9% to $1.88. The market value of their outstanding shares is at $23.2 million.
    • MedAvail Holdings (NASDAQ:MDVL) stock moved upwards by 9.55% to $3.9. The market value of their outstanding shares is at $6.2 million.
    • Kenvue (NYSE:KVUE) stock moved upwards by 5.47% to $22.16. The market value of their outstanding shares is at $42.4 billion.
    • Davis Commodities (NASDAQ:DTCK) stock increased by 4.04% to $1.03. The company's market cap stands at $25.0 million.
    • Flora Growth (NASDAQ:FLGC) stock increased by 3.96% to $1.31. The market value of their outstanding shares is at $10.7 million.

    Losers

    • Mama`s Creations (NASDAQ:MAMA) shares declined by 8.7% to $3.57 during Monday's after-market session. The market value of their outstanding shares is at $133.0 million. As per the press release, Q3 earnings came out 4 days ago.
    • Maison Solutions (NASDAQ:MSS) stock declined by 7.95% to $2.2. The company's market cap stands at $43.3 million. As per the press release, Q2 earnings came out today.
    • Shineco (NASDAQ:SISI) stock fell 6.17% to $0.09. The company's market cap stands at $4.7 million.
    • Elevai Labs (NASDAQ:ELAB) stock declined by 5.21% to $1.82. The company's market cap stands at $31.5 million.
    • Mangoceuticals (NASDAQ:MGRX) shares declined by 2.88% to $0.27. The market value of their outstanding shares is at $4.7 million.
    • AgriFORCE Growing Systems (NASDAQ:AGRI) stock fell 2.0% to $0.56. See Also: www.benzinga.com/money/best-consumer-defensive-stocks/

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $AGRI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGRI
    $BTTR
    $CHSN
    $DTCK

    CompanyDatePrice TargetRatingAnalyst
    Kenvue Inc.
    $KVUE
    1/30/2026$18.00Buy → Hold
    Jefferies
    Kenvue Inc.
    $KVUE
    10/29/2025$15.00Buy → Hold
    Canaccord Genuity
    Kenvue Inc.
    $KVUE
    9/26/2025$22.00Neutral → Buy
    Rothschild & Co Redburn
    Mama's Creations Inc.
    $MAMA
    9/23/2025$18.00Buy
    DA Davidson
    Kenvue Inc.
    $KVUE
    4/10/2025$23.50Neutral
    Redburn Atlantic
    Kenvue Inc.
    $KVUE
    3/24/2025$25.00In-line
    Evercore ISI
    Kenvue Inc.
    $KVUE
    1/6/2025$21.00 → $26.00Neutral → Overweight
    Piper Sandler
    Kenvue Inc.
    $KVUE
    12/12/2024$25.00 → $24.00Buy → Hold
    Deutsche Bank
    More analyst ratings

    $AGRI
    $BTTR
    $CHSN
    $DTCK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Kenvue downgraded by Jefferies with a new price target

    Jefferies downgraded Kenvue from Buy to Hold and set a new price target of $18.00

    1/30/26 6:43:10 AM ET
    $KVUE
    Specialty Chemicals
    Consumer Discretionary

    Kenvue downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Kenvue from Buy to Hold and set a new price target of $15.00

    10/29/25 7:19:36 AM ET
    $KVUE
    Specialty Chemicals
    Consumer Discretionary

    Kenvue upgraded by Rothschild & Co Redburn with a new price target

    Rothschild & Co Redburn upgraded Kenvue from Neutral to Buy and set a new price target of $22.00

    9/26/25 8:00:14 AM ET
    $KVUE
    Specialty Chemicals
    Consumer Discretionary

    $AGRI
    $BTTR
    $CHSN
    $DTCK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief People Officer Alvarado Luani converted options into 15,942 shares and covered exercise/tax liability with 5,468 shares, increasing direct ownership by 22% to 57,076 units (SEC Form 4)

    4 - Kenvue Inc. (0001944048) (Issuer)

    2/18/26 8:35:24 PM ET
    $KVUE
    Specialty Chemicals
    Consumer Discretionary

    Chief Operations Officer Stevens Meredith converted options into 28,040 shares and covered exercise/tax liability with 8,031 shares, increasing direct ownership by 30% to 86,046 units (SEC Form 4)

    4 - Kenvue Inc. (0001944048) (Issuer)

    2/18/26 8:35:30 PM ET
    $KVUE
    Specialty Chemicals
    Consumer Discretionary

    VP & Chief Accounting Officer Howlett Heather converted options into 13,571 shares and covered exercise/tax liability with 4,649 shares, increasing direct ownership by 42% to 30,190 units (SEC Form 4)

    4 - Kenvue Inc. (0001944048) (Issuer)

    2/18/26 8:35:14 PM ET
    $KVUE
    Specialty Chemicals
    Consumer Discretionary

    $AGRI
    $BTTR
    $CHSN
    $DTCK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $AGRI
    $BTTR
    $CHSN
    $DTCK
    SEC Filings

    View All

    $AGRI
    $BTTR
    $CHSN
    $DTCK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program

    Month over Month Growth of 336% and 54% Reduction in Customer Acquisition Cost (CAC) DALLAS, TX, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) (the "Company" or "MangoRx"), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands MangoRx and PeachesRx, today announced that MangoRx has experienced initial success for its newly launched all-inclusive injectable Testosterone Replacement Therapy (TRT) treatment program priced at $99 per month. The new TRT offer includes all doctor visits and medical consultations, lab work and analysis, and the medication to the extent prescribe

    2/19/26 4:05:00 PM ET
    $MGRX
    Misc Health and Biotechnology Services
    Health Care

    Kenvue Reports Fourth Quarter and Full Year 2025 Results

    Q4 Net Sales 3.2%; Organic Sales1 1.2% Q4 Diluted EPS was $0.17; Adjusted Diluted EPS1 was $0.27 FY'25 Net Sales (2.1)%; Organic Sales (2.2)% FY'25 Diluted EPS was $0.76; Adjusted Diluted EPS was $1.08 Kenvue Inc. (NYSE:KVUE) today announced financial results for the fiscal fourth quarter and full year ended December 28, 2025. "We ended 2025 with stronger top- and bottom-line performance in the fourth quarter, which reflected both disciplined execution against our strategic priorities, as well as a more favorable year-ago comparison on sales," said Kirk Perry, Chief Executive Officer. "As we look to 2026, we remain focused on continuing to enhance our performance, while progr

    2/17/26 4:45:00 PM ET
    $KVUE
    Specialty Chemicals
    Consumer Discretionary

    Davis Commodities Deploys AI-Driven Logistics to Improve Margins, Strengthen Cash Flow and Support Scalable Growth

    SINGAPORE, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Davis Commodities Limited ("Davis Commodities" or the "Company"), a leading global agricultural commodities trading firm listed on Nasdaq under the ticker "DTCK", is enhancing its profitability and capital efficiency through the strategic deployment of artificial intelligence ("AI") across its logistics and supply chain operations. This initiative is designed to improve gross margins, shorten cash conversion cycles and support scalable growth as the Company expands its presence in Asia, Africa and the Middle East. Enhancing Efficiency and Margins Across a Complex Global Supply Chain Operating across multiple geographies, product categories an

    2/10/26 9:30:00 AM ET
    $DTCK
    Farming/Seeds/Milling
    Industrials

    SEC Form 10-K filed by Kenvue Inc.

    10-K - Kenvue Inc. (0001944048) (Filer)

    2/20/26 7:13:06 AM ET
    $KVUE
    Specialty Chemicals
    Consumer Discretionary

    Mangoceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - MANGOCEUTICALS, INC. (0001938046) (Filer)

    2/19/26 4:05:51 PM ET
    $MGRX
    Misc Health and Biotechnology Services
    Health Care

    Kenvue Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Costs Associated with Exit or Disposal Activities, Financial Statements and Exhibits

    8-K - Kenvue Inc. (0001944048) (Filer)

    2/17/26 4:46:12 PM ET
    $KVUE
    Specialty Chemicals
    Consumer Discretionary

    Director Smith Jeffrey C bought $110,986,526 worth of shares (6,377,694 units at $17.40) (SEC Form 4)

    4 - Kenvue Inc. (0001944048) (Issuer)

    12/15/25 4:00:25 PM ET
    $KVUE
    Specialty Chemicals
    Consumer Discretionary

    Director Welch David Ryan was granted 97,410 shares and bought $1,424 worth of shares (11 units at $129.42), increasing direct ownership by 647% to 97,421 units (SEC Form 4)

    4 - AGRIFORCE GROWING SYSTEMS LTD. (0001826397) (Issuer)

    9/30/25 7:56:59 PM ET
    $AGRI
    Metal Fabrications
    Industrials

    Chief Operating Officer Cao Xi bought $71 worth of shares (58 units at $1.22) and sold $70 worth of shares (58 units at $1.21) (SEC Form 4)

    4 - Maison Solutions Inc. (0001892292) (Issuer)

    3/19/25 4:38:30 PM ET
    $MSS
    Food Chains
    Consumer Staples

    $AGRI
    $BTTR
    $CHSN
    $DTCK
    Financials

    Live finance-specific insights

    View All

    Kenvue Reports Fourth Quarter and Full Year 2025 Results

    Q4 Net Sales 3.2%; Organic Sales1 1.2% Q4 Diluted EPS was $0.17; Adjusted Diluted EPS1 was $0.27 FY'25 Net Sales (2.1)%; Organic Sales (2.2)% FY'25 Diluted EPS was $0.76; Adjusted Diluted EPS was $1.08 Kenvue Inc. (NYSE:KVUE) today announced financial results for the fiscal fourth quarter and full year ended December 28, 2025. "We ended 2025 with stronger top- and bottom-line performance in the fourth quarter, which reflected both disciplined execution against our strategic priorities, as well as a more favorable year-ago comparison on sales," said Kirk Perry, Chief Executive Officer. "As we look to 2026, we remain focused on continuing to enhance our performance, while progr

    2/17/26 4:45:00 PM ET
    $KVUE
    Specialty Chemicals
    Consumer Discretionary

    Kenvue to Announce Fourth Quarter and Full Year 2025 Results on February 17, 2026

    Kenvue Inc. (NYSE:KVUE) will announce its fourth quarter and full year 2025 financial results after market close on February 17, 2026. Due to the pending transaction with Kimberly-Clark, Kenvue will not be hosting a quarterly conference call to review its financial results. The press release will be available on the company's website at investors.kenvue.com. About Kenvue Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson's®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue,

    2/4/26 6:45:00 AM ET
    $KVUE
    Specialty Chemicals
    Consumer Discretionary

    Kenvue Declares Quarterly Cash Dividend

    Kenvue Inc. (NYSE:KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock. The quarterly dividend is payable on February 25, 2026, to shareholders of record as of the close of business on February 11, 2026. About Kenvue Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson's®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we realize the extraordinary power of everyday care. Our teams work every day to put that po

    1/28/26 6:45:00 AM ET
    $KVUE
    Specialty Chemicals
    Consumer Discretionary

    $AGRI
    $BTTR
    $CHSN
    $DTCK
    Leadership Updates

    Live Leadership Updates

    View All

    SRx Health Solutions Appoints Sammy Dorf to Board of Directors

    TAMPA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced the appointment of Sammy Dorf, Esq. to its Board of Directors. Sammy is a pioneering force in the modern cannabis economy and one of the industry's most accomplished dealmakers, strategists, and growth architects. Most recently serving as Executive Chairman of Flora Growth Corp. (NASDAQ:FLGC), Sammy guided the company through a transformative phase marked by innovation, disciplined expansion, and a strategic transition into a crypto treasury company. With nearly a decade of leadership at the intersection of cannabis, capital markets, and strategic development, Sammy b

    11/10/25 8:00:00 AM ET
    $FLGC
    $SRXH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Beverages (Production/Distribution)
    Consumer Staples

    Flora Growth Corp. Appoints BitGo as Custodian for $0G Treasury

    Fort Lauderdale, Florida--(Newsfile Corp. - October 16, 2025) - Flora Growth Corp. (NASDAQ:FLGC), which is set to rebrand as ZeroStack (the "Company"), the first and largest decentralized AI treasury company, has appointed BitGo Trust Company, Inc. ("BitGo") to provide institutional-grade custody for the Company's $0G treasury.BitGo, the digital asset infrastructure company, has enabled its clients to securely navigate the digital asset space since 2013 by delivering custody, wallets, staking, trading, financing, and settlement services from regulated cold storage. The appointment of BitGo is proof of the Company's focused approach to transparency, security, regulatory compliance and operati

    10/16/25 8:00:00 AM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Shineco Establishes Biological Cell Digital Division to Integrate Biological Cell Assets and Blockchain Technology

    BEIJING, Aug. 13, 2025 /PRNewswire/ -- Shineco Inc. ((", Shineco", or the ", Company", , NASDAQ:SISI), a manufacturer of induced pluripotent stem cell (iPSC) technology platforms, today announced the establishment of a Biological Cell Digital Business Division (the "Division"), and the appointment of Mr. Lin Hongguang as General Manager, to advance the integration of its biological cell assets and blockchain technology. Through a new architecture of blockchain-based cell assets, Shineco aims to build a vertical ecosystem within the biological cell sector, accelerate the global distribution of biological cell products and boost global sales. The Division is expected to use blockchain technol

    8/13/25 6:30:00 AM ET
    $SISI
    Medicinal Chemicals and Botanical Products
    Health Care

    $AGRI
    $BTTR
    $CHSN
    $DTCK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:02:53 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:01:40 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13D filed by Davis Commodities Limited

    SC 13D - DAVIS COMMODITIES Ltd (0001949478) (Subject)

    12/10/24 8:00:12 AM ET
    $DTCK
    Farming/Seeds/Milling
    Industrials